Evidence map›Paper›PMID 41159544›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

The Crosstalk Between CRL5 and APC/C E3 Ligases Regulates Metastasis and Chemosensitivity of Cancer Cells.

Danrui Cui, Ruirui Qu, Tianqi Li, Linchen Wang, Xiaoyu Chen, Shengpeng Shao, Xue Liang, Jun Xu, Yi Sun, Xiufang Xiong and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Danrui CuiDepartment of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Ruirui QuDepartment of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Tianqi LiDepartment of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Linchen WangDepartment of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Xiaoyu ChenDepartment of Medical Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Shengpeng ShaoDepartment of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Xue LiangDepartment of Medical Oncology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Jun XuInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310029, China.
Yi SunInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310029, China.
Xiufang XiongInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310029, China.
Yongchao ZhaoDepartment of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.ORCID https://orcid.org/0000-0003-4610-4182

Funding

National Key R&D Program of China 2022YFC3401500National Natural Science Foundation of China 32471300National Natural Science Foundation of China 81972591National Natural Science Foundation of China 81974429National Natural Science Foundation of China 82002924National Natural Science Foundation of China 82172898National Natural Science Foundation of China 82188102National Natural Science Foundation of China 82403014National Natural Science Foundation of China 92053117Natural Science Foundation of Zhejiang Province LY22H160029Natural Science Foundation of Zhejiang Province LZ22H160003
6 · The paper itself

Abstract

Cullin-RING ligases (CRLs) and the anaphase-promoting complex/cyclosome (APC/C) are two major multi-subunit ubiquitin ligases essential for protein homeostasis. The underlying mechanism and biological consequence of their crosstalk remain elusive. Here, tandem affinity purification followed by LC-MS/MS is employed, and identified APC11-the RING subunit of APC/C-as a bona fide binding partner of CUL5, the scaffold of CRL5. On one hand, APC11 interacts with CUL5 and inhibits its neddylation. Consequently, APC11 knockdown enhances CUL5 neddylation by promoting its interaction with the neddylation E2 UBE2F. This leads to the degradation of SOCS3, a substrate receptor of CRL5, and the subsequent accumulation of its substrate, integrin β1, ultimately promoting cancer metastasis. On the other hand, CUL5-APC11 binding stabilizes APC11 by facilitating its atypical K27/K29/K33-linked polyubiquitylation at Lys83, a process catalyzed by ITCH E3 ligase. CUL5 loss delays mitotic exit, induces aneuploidy, and sensitizes cancer cells to the microtubule-targeting drug paclitaxel by destabilizing APC11. Collectively, the study revealed a new crosstalk between CUL5 and APC11 of two major E3 ligases, and targeting this crosstalk can provide a new strategy for blocking metastasis and triggering chemosensitization.

Indexed as

Anaphase-Promoting Complex-CyclosomeCullin ProteinsNeoplasmsUbiquitin-Protein LigasesAnimalsCell Line, TumorHumansMiceNeoplasm MetastasisAnaphase-Promoting Complex-CyclosomeCUL5 protein, humanCullin ProteinsUbiquitin-Protein LigasesAPC11chemosensitivityCUL5metastasisneddylation

Identifiers

PMID41159544
PMCPMC12806337

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.